Fig. S1. Inhibitor studies of β2-spectrin cleavage. (A) C-terminal V5-tagged β2-Spectrin-transfected Huh7 cells were treated with 10 mM acetaminophen for 48 h in the absence or presence of 10 µM LY2019761, an inhibitor of TGF-β receptor I/II, and analyzed via Western blot using antibodies against the V5 epitope. (B) β2-Spectrintransfected Huh7 cells were incubated with 100 pM TGF-β for 8 h in the absence or presence of 100 µM Z-VAD-FMK, an inhibitor of pan-caspase. (C) β2-Spectrintransfected COS7 cells were treated with 100 pM Z-VAD-FMK for 12 h. β-actin was used as the loading control.
